Correlation Between Rakovina Therapeutics and Marvel Biosciences
Can any of the company-specific risk be diversified away by investing in both Rakovina Therapeutics and Marvel Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rakovina Therapeutics and Marvel Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rakovina Therapeutics and Marvel Biosciences Corp, you can compare the effects of market volatilities on Rakovina Therapeutics and Marvel Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rakovina Therapeutics with a short position of Marvel Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rakovina Therapeutics and Marvel Biosciences.
Diversification Opportunities for Rakovina Therapeutics and Marvel Biosciences
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Rakovina and Marvel is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Rakovina Therapeutics and Marvel Biosciences Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marvel Biosciences Corp and Rakovina Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rakovina Therapeutics are associated (or correlated) with Marvel Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marvel Biosciences Corp has no effect on the direction of Rakovina Therapeutics i.e., Rakovina Therapeutics and Marvel Biosciences go up and down completely randomly.
Pair Corralation between Rakovina Therapeutics and Marvel Biosciences
Assuming the 90 days horizon Rakovina Therapeutics is expected to generate 1.58 times more return on investment than Marvel Biosciences. However, Rakovina Therapeutics is 1.58 times more volatile than Marvel Biosciences Corp. It trades about 0.11 of its potential returns per unit of risk. Marvel Biosciences Corp is currently generating about 0.14 per unit of risk. If you would invest 8.00 in Rakovina Therapeutics on September 2, 2024 and sell it today you would earn a total of 1.00 from holding Rakovina Therapeutics or generate 12.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Rakovina Therapeutics vs. Marvel Biosciences Corp
Performance |
Timeline |
Rakovina Therapeutics |
Marvel Biosciences Corp |
Rakovina Therapeutics and Marvel Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Rakovina Therapeutics and Marvel Biosciences
The main advantage of trading using opposite Rakovina Therapeutics and Marvel Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rakovina Therapeutics position performs unexpectedly, Marvel Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marvel Biosciences will offset losses from the drop in Marvel Biosciences' long position.Rakovina Therapeutics vs. Walmart Inc CDR | Rakovina Therapeutics vs. Amazon CDR | Rakovina Therapeutics vs. Berkshire Hathaway CDR | Rakovina Therapeutics vs. UnitedHealth Group CDR |
Marvel Biosciences vs. Leveljump Healthcare Corp | Marvel Biosciences vs. Rakovina Therapeutics | Marvel Biosciences vs. Marvel Discovery Corp | Marvel Biosciences vs. XORTX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |